Open AccessDectiSomes: Glycan Targeting of Liposomal Drugs Improves the Treatment of Disseminated Candidiasis
Author(s) -
Suresh Ambati,
Tuyetnhu Pham,
Zachary Lewis,
Xiaorong Lin,
Richard B. Meagher
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01467-21
Subject(s) - candida albicans , glycan , immune system , medicine , liposome , anti infective agents , invasive candidiasis , immunology , pharmacology , antifungal , intensive care medicine , biology , microbiology and biotechnology , antimicrobial , fluconazole , dermatology , glycoprotein , biochemistry
Candida albicans causes life-threatening disseminated candidiasis. Individuals at greatest risk have weakened immune systems.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom